白云山子公司注射用头孢他啶通过仿制药一致性评价

Core Viewpoint - Baiyunshan's subsidiary, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for its injectable Cefoperazone, indicating a successful evaluation of the drug's quality and efficacy consistency as a generic medication [1] Group 1 - Baiyunshan's announcement highlights the approval of injectable Cefoperazone (0.5g, 1.0g) as a third-generation cephalosporin antibiotic [1] - The drug is indicated for the treatment of infections caused by sensitive microorganisms, whether singular or multiple [1]